Effects of Freeze-dried Grape Powder on Immune Profiles in Healthy Aging Adults
Part of paid clinical trials in Storrs, Connecticut.
- Sponsor
- University of Connecticut
- Study ID
- NCT07079982
- Status
- Recruiting
Conditions
- Healthy Aging
- Inflammation
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Freeze-dried whole grape powder — OTHERStudying the effects of freeze-dried whole grape powder on immune profiles in healthy aging adults
- Control grape-free powder — OTHERStudying effects of a control grape-free powder on immune profiles in healthy aging
Study Details
The purpose of this study is to investigate the effects of consuming grape powder on immune profiles in healthy middle- and older-aged individuals. Specifically, the investigators are interested in evaluating the potential effects of grapes in influencing markers of immune function, inflammation, and metabolism that are known to change with aging. Grapes contain several nutrients and antioxidant polyphenols such as resveratrol, quercetin, vitamin K and fiber, which are known to promote heart and immune health. However, the effects of grapes on altering immune profiles within the context of aging is not well understood. Therefore, this study will explore how daily grape consumption impacts certain markers of immunity in healthy middle- and older-aged adults. The main study procedures include consumption of a freeze-dried grape powder and control powder (which tastes the same but has none of the grape compounds that are being studied) mixed with water as a beverage on a daily basis for 4 weeks each. The investigators will additionally ask that participants avoid eating grapes and certain other antioxidant/grape-related foods and beverages throughout the 13-week study. Participants will additionally be asked to complete surveys about their diet, physical activity, and medical history, as well as provide blood samples and body weight measures throughout the course of the study. Participation in the study is expected to last about 6.25 hours over the course of 13 weeks and will include 7 visits.
Key Dates
- Start date
- Jul 25, 2025
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 28 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Freeze-dried whole grape powder
- Placebo Comparator: Control grape-free powder
Primary Outcome Measure
Concentration of lipopolysaccharide (LPS)-induced interleukin-1 beta (IL-1beta) secreted from subject-derived primary immune cells ex vivo [ Time Frame: 4 weeks ]
Central Contacts
- Catherine J Andersen, PhD, RDN860-486-1704
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Department of Nutritional Sciences | Storrs | Connecticut | 06269 |
Find similar trials in Storrs, CT
Related Studies
- Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskPHASE3 · Recruiting · Population Health Research Institute · New Haven, Connecticut
- Cognitive RemediationRecruiting · Cutter Lindbergh · Farmington, Connecticut
- Evaluation and Long-Term Follow-up of Patients With Inflammatory DisordersEnrolling By Invitation · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Immune Cell Response to StimuliRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Research Triangle Park, North Carolina